Tag Archives: Eli Lilly & Co.

Photo by Michael Nagle / Bloomberg

Lilly Wins U.S. Patent Challenges to Its Alimta Cancer Drug

Lilly Wins U.S. Patent Challenges to Its Alimta Cancer Drug

By Susan Decker and Tatiana Darie, Bloomberg News Eli Lilly & Co. won a challenge to the validity of a patent that keeps generic versions of its $2 billion lung cancer drug Alimta off the U.S. market until 2022. The Patent Trial and Appeal Board rejected arguments by companies including Teva Pharmaceutical Industries Ltd., Novartis

Top